Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

UK pharma body urges govt to scrap hike in repayment rate for drugmakers

Published 02/02/2023, 00:13
Updated 02/02/2023, 00:35
© Reuters. FILE PHOTO-A trainee pharmacy staff member puts in order medications on shelves during a visit of Scotland's First Minister Nicola Sturgeon as part of the launching of the Scottish Apprenticeship Week, at Monklands University Hospital, in Airdrie, Scotlan

© Reuters. FILE PHOTO-A trainee pharmacy staff member puts in order medications on shelves during a visit of Scotland's First Minister Nicola Sturgeon as part of the launching of the Scottish Apprenticeship Week, at Monklands University Hospital, in Airdrie, Scotlan

(Reuters) - UK's pharmaceutical trade body on Thursday called for the government to scrap its plans to raise the repayment rates for drugmakers, to avoid possible setbacks in the sector.

Drugmakers that are part of UK's voluntary scheme agreement, which makes branded medicines affordable for people, are required to pay a part of their drug revenue to the government. The Department of Health and Social Care plans to raise the revenue clawback rate to 27.5% from 24.5%.

The country's ongoing attempt to raise rates is likely to send the "worst possible signal" to global investors and boardrooms, said the Association of the British Pharmaceutical Industry (ABPI).

"Hiking these clawbacks to such uncompetitive levels risks undermining the UK's offer to global life sciences companies," Richard Torbett, chief executive of the ABPI, said in a statement.

Pharmaceuticals giants AbbVie (NYSE:ABBV) and Eli Lilly (NYSE:LLY) withdrew from the UK's voluntary drug pricing agreement in January after the repayment rates surged to 26.5%.

ABPI has asked for the existing rates to be terminated at the end of 2023, while keeping it unchanged for now to buy time for negotiations.

© Reuters. FILE PHOTO-A trainee pharmacy staff member puts in order medications on shelves during a visit of Scotland's First Minister Nicola Sturgeon as part of the launching of the Scottish Apprenticeship Week, at Monklands University Hospital, in Airdrie, Scotland, Britain March 7, 2022. Andy Buchanan/Pool via REUTERS

The industry body said the government policies could further depress investments in UK's life science sector in the long term.

($1 = 0.8106 pounds)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.